Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study.
AUTHORS
Roumie
CL ,
Min
JY ,
D'Agostino McGowan
L ,
Presley
C ,
Grijalva
CG ,
Hackstadt
AJ ,
Hung
AM ,
Greevy
RA ,
Elasy
T ,
Griffin
MR ,
. Journal of the American Heart Association. 2017 4 19; 6(4).
- PMID: 28424149 [PubMed].
ABSTRACT
Medications that impact insulin sensitivity or cause weight gain may increase heart failure risk. Our aim was to compare heart failure and cardiovascular death outcomes among patients initiating sulfonylureas for diabetes mellitus treatment versus metformin.
Medications that impact insulin sensitivity or cause weight gain may increase heart failure risk. Our aim was to compare heart failure and cardiovascular death outcomes among patients initiating sulfonylureas for diabetes mellitus treatment versus metformin.
Tags: Alumni Publications 2017